Agios Pharmaceuticals Inc. buy Truist Financial Co.
Start price
24.11.25
/
50%
€23.00
Target price
24.11.26
-
Performance (%)
26.96%
Price
13.08.26
€29.20
Summary
This prediction is currently active. The prediction currently has a performance of 26.96%. This prediction currently runs until 24.11.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | 5.036% | 5.036% |
| iShares Core DAX® | 0,88 % | 5,63 % |
| iShares Nasdaq 100 | 2,39 % | 1,57 % |
| iShares Nikkei 225® | 4,27 % | 2,52 % |
| iShares S&P 500 | 1,17 % | 2,55 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.00
31.07.26
31.07.26
€33.88
31.07.27
31.07.27
13.85%
13.08.26
13.08.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€33.60
07.07.26
07.07.26
€35.85
07.07.27
07.07.27
-13.10%
13.08.26
13.08.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.00
30.04.26
30.04.26
€30.85
30.04.27
30.04.27
21.67%
13.08.26
13.08.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.80
24.12.25
24.12.25
€32.19
24.12.26
24.12.26
22.69%
13.08.26
13.08.26